Miguel Freitas, PhD

VP Health and Scientific Affairs at Danone North America
On the record
Represented by:
Bio

Miguel Freitas, PhD, VP Health and Scientific Affairs at Danone North America
Miguel Freitas, PhD, is one of the world’s leading experts on the complex interactions between probiotics, the gut and the microbiota. As vice president of scientific affairs at Danone North America, he has helped the global food and beverage company translate the growing body of evidence on different probiotic strains into a range of consumer products.
As a nutrition scientist and microbiologist, he has published several peer-reviewed studies on microbes and human health, and is a frequent speaker at scientific conferences around the world. Since joining Danone more than two decades ago, Dr. Freitas has been a driving force behind new fermented dairy innovations containing both probiotics and prebiotics.
In his current role, Dr. Freitas collaborates with leading researchers worldwide to drive science and innovation related to probiotics. He has experience designing research protocols and working with scientists to understand how probiotics work in the body and what are the best bacterial strains to incorporate in Danone’s cultured products for specific desired benefits. Dr. Freitas also closely works with the medical community, including healthcare professionals and key opinion leaders to accelerate knowledge sharing of the latest discoveries on how probiotics and prebiotics can impact health.
Dr. Freitas is a professional member of the American Gastroenterological Association (AGA) and American Society for Nutrition (ASN), and is an advisory board member of Future Food Tech. He also serves as director of the Danone Institute North America, a non-profit foundation that helps advance community-based work to promote sustainable food systems globally. For nearly a decade, Dr. Freitas has helped oversee fellowship grants for microbiome research.
Dr. Freitas earned a PhD from the National Institute of Health and Medical Research (INSERM) in Paris, France, with his dissertation focused on how a specific strain of Lactobacillus casei helps to support the immune system.

Recent Quotes
Sign up to view all
  • This year, we received a wide variety of high-caliber applications. It is evident that these students are poised to contribute to advances in our understanding of the gut microbiome and human health upon the reopening of their educational institutions. At Danone North America, we are honored to help further the field and support the future of these high-quality researchers

    5 December 2020
Employment
Sign up to view all
Popularity